Hanis Abdul Kadir

Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs

Carolyn S.P. Lam, Shun Kohsaka, Avraham Karasik et al. · Journal of the American College of Cardiology · 2018 · 466 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study

Shun Kohsaka, Carolyn S.P. Lam, Dae Jung Kim et al. · The Lancet Diabetes & Endocrinology · 2020 · 93 citations · Full text

Medicine, Cardiology, Pharmacology +12

Establishment of the SingHealth Diabetes Registry

Daniel Yan Zheng Lim, Sing Yi Chia, Hanis Abdul Kadir et al. · Clinical Epidemiology · 2021 · 45 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +16

Effective Treatment Recommendations for Type 2 Diabetes Management Using Reinforcement Learning: Treatment Recommendation Model Development and Validation

Xingzhi Sun, Yong Mong Bee, Shao Wei Lam et al. · Journal of Medical Internet Research · 2021 · 29 citations · Full text

Medicine, Health Informatics, Clinical Decision Support +15

Cardiovascular outcomes with sodium–glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data

Kamlesh Khunti, Mikhail Kosiborod, Dae Jung Kim et al. · Cardiovascular Diabetology · 2021 · 29 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17